AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $293,000 | -24.9% | 102,100 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $390,000 | +23.0% | 102,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $317,000 | +13.6% | 102,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $279,000 | +16.7% | 102,100 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $239,000 | -60.6% | 102,100 | -30.6% | 0.00% | -75.0% |
Q3 2019 | $606,000 | -59.6% | 147,100 | -54.6% | 0.00% | -50.0% |
Q2 2019 | $1,501,000 | +782.9% | 324,200 | +1473.8% | 0.01% | +700.0% |
Q1 2019 | $170,000 | +78.9% | 20,600 | +20.5% | 0.00% | 0.0% |
Q4 2018 | $95,000 | -44.1% | 17,100 | -17.0% | 0.00% | 0.0% |
Q3 2018 | $170,000 | -11.9% | 20,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $193,000 | -4.0% | 20,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $201,000 | +32.2% | 20,600 | +21.2% | 0.00% | -50.0% |
Q1 2016 | $152,000 | -18.7% | 17,000 | +15.6% | 0.00% | 0.0% |
Q4 2015 | $187,000 | +33.6% | 14,700 | +1.4% | 0.00% | 0.0% |
Q3 2015 | $140,000 | +0.7% | 14,500 | +7.4% | 0.00% | 0.0% |
Q2 2015 | $139,000 | +31.1% | 13,500 | +42.1% | 0.00% | +100.0% |
Q1 2015 | $106,000 | – | 9,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |